Drug interventions can regulate the alternative splicing of LDLR pre-mRNA and increase normal LDLR transcripts in hypercholesterolemic patients by affecting the expression of histone methylation and acetylation and controlling hypercholesterolemia [34,35,36]. This evidence concerns the gene LDLR and familial hypercholesterolemia.